DH NASDAQ
Definitive Healthcare Corp.
1W: -4.6%
1M: -26.8%
3M: -45.7%
YTD: -65.5%
1Y: -75.2%
3Y: -90.9%
$0.85
+0.03 (+3.91%)
Weekly Expected Move ±10.5%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
0 bullish
1 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (17)
Can Definitive Healthcare Corp. (DH) Maintain Stability After Revised Price Target From Baird?
Definitive Healthcare forecasts $220M-$226M FY2026 revenue while guiding Q2 EBITDA margin at 24%-26%
Definitive Healthcare Corp. (DH) Tops Q1 Earnings Estimates
DH Q1 2026 Earnings Transcript
Teradata (TDC) Tops Q1 Earnings and Revenue Estimates
Docebo Inc. (DCBO) Reports Next Week: Wall Street Expects Earnings Growth
Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for
Definitive Healthcare Corp. (NASDAQ:DH) Receives Average Recommendation of “Reduce” from Brokerages
Definitive Healthcare Corp. (NASDAQ:DH) Given Average Rating of “Reduce” by Brokerages
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1
Definitive Healthcare Corp. (DH) Q4 2025 Earnings Call Transcript
Definitive Healthcare GAAP EPS of -$0.09 misses by $0.03, revenue of $61.5M beats by $1.93M
Definitive Healthcare Corp. (DH) Matches Q4 Earnings Estimates
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025
Definitive Healthcare Corp. (NASDAQ:DH) Receives Average Rating of “Hold” from Brokerages
Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast
Definitive Healthcare to Present at the 28th Annual Needham Growth Conference